CamilleCatherineGundersonMD

Obstetrics & Gynecology • Oklahoma City, OK

Gynecologic Oncology

Assistant Professor

Join to view full profile

Dr. Gunderson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gunderson's full profile

Already have an account?

Office
4401 McAuley Blvd
Ste 2200
Oklahoma City, OK 73120
Phone+1 405-749-7023

Fax+1 405-749-7025

Education & Training

Johns Hopkins UniversityResidency, Obstetrics and Gynecology, 2008 - 2012
Louisiana State University School of Medicine in New OrleansClass of 2008

Certifications & Licensure

OK State Medical License 2012 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium Start of enrollment: 2018 Jun 29
Completed
Phase 2
Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer Start of enrollment: 2018 Aug 08
Active, not recruiting
Phase 2

Publications & Presentations

PubMed

Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II T...
Joyce F Liu, Stéphanie Gaillard, Andrea E Wahner Hendrickson, Oladapo Yeku, Elisabeth Diver
JCO Precision Oncology. 2024-05-01
4 citations
NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endomet...
Bobbie J Rimel, Danielle Enserro, David P Bender, Camille Gunderson Jackson, Annie Tan
Cancer. 2024-04-15
2 citations
Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic...
Ian S Hagemann, Wei Deng, Richard J Zaino, Matthew A Powell, Camille Gunderson Jackson
Gynecologic Oncology. 2023-10-01

Journal Articles

Prediction of Chemotherapy Response in Ovarian Cancer Patients Using a New Clustered Quantitative Image Marker
Theresa Thai, Camille Gunderson, IOPscience

Press Mentions

Society of Gynecologic Oncology 50th Anniversary: Camille C. Gunderson, MDMay 29th, 2019